skip to main content

Inaugural 2026 Seedling Grant Awardees

Through the Dementia and Alzheimer’s Research Initiative (DARI), Texas A&M has awarded $1.325 million to support 11 multidisciplinary research projects focused on improving brain health and accelerating innovation in Alzheimer’s disease and related dementias.

The inaugural DARI Seedling Grants were awarded following a rigorous, nine-month review process:

  • 112 pre-proposals submitted from across Texas A&M University

  • 25 finalist teams invited to submit full proposals

  • Projects evaluated through internal and external expert review, a study section panel and administrative review

The selected projects reflect the breadth and depth of dementia-related research underway at Texas A&M, spanning biomedical science, engineering, public health, architecture, education and beyond.

2026 DARI Seedling Grant Awardees

The inaugural awardees address the full continuum of dementia research, including early detection, biomarkers, prevention strategies, novel therapeutics, AI-enabled diagnostics, caregiver support and built-environment solutions.

  • Sensor-Augmented Multimodal ‘Digital Apathy Signature’ for the Early Detection of Apathy and Dementia Risk
    Mark Benden, PhD—School of Public Health

  • Development of Blood-Brain Barrier-Penetrating Peptide Shuttle Vectors for the Treatment of Neuroinflammatory and Neurodegenerative Diseases
    Peter Davies, MD, PhD—Naresh K. Vashisht College of Medicine

  • Evaluation of Clostridioides Difficile Virulence Factors in the Development of Dementia and Alzheimer’s Disease
    Marjorie Pizarro-Guajardo, PhD—College of Arts & Sciences

  • Innate Immune Signaling & LINE-1 Retrotransposons as Precision-Based Biomarkers for Alzheimer’s Dementia
    Kenneth Ramos, MD, PhD—Institute of Biosciences & Technology

  • Intranasal, Magnetically Guided Delivery of Clusterin Enhancers to Slow Down Cognitive Decline in Alzheimer’s Disease
    Ashok Shetty, PhD—Naresh K. Vashisht College of Medicine

  • Disrupted Circadian Rhythms as a Driver of Inflammation and Cognitive Decline: Targeting Neuroimmune Mechanisms for Early Intervention
    Karienn Souza, PhD—Naresh K. Vashisht College of Medicine

  • Repurposing the Smoking Cessation Drug Cytisine as a Prophylactic Against Conversion of Mild Cognitive Impairment to Alzheimer’s Disease and Related Dementias
    Rahul Srinivasan, PhD—Naresh K. Vashisht College of Medicine

  • Nutrient-Sensing GHSR Mediates Transgenerational Neurotoxicity of Environmental Toxicant BPA to Promote Neuroinflammation and Alzheimer’s Disease
    Yuxiang Sun, MD, PhD—College of Agriculture & Life Sciences

  • Gait Biomarkers for Early Diagnosis of Alzheimer’s Disease & Related Dementias
    Jenna Yentes, PhD—College of Education & Human Development

  • Multimodal AI Reasoning Models for Early Diagnosis and Understanding of Alzheimer’s Disease
    Tianbao Yang, PhD—College of Engineering

  • Reimagine Homes for Living with Dementia: Support Safety, Independence, and Autonomy through a Smart Homecare Digital Twin
    Xuemei Zhu, PhD—College of Architecture

This page will be updated as projects progress and additional DARI initiatives are announced.